Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.
Mizuno T, Kojima Y, Yonemori K, Yoshida H, Sugiura Y, Ohtake Y, Okuma HS, Nishikawa T, Tanioka M, Sudo K, Shimomura A, Noguchi E, Kato T, Shimoi T, Uno M, Ishikawa M, Fujiwara Y, Ohe Y, Tamura K.
Mizuno T, et al. Among authors: uno m.
Oncol Lett. 2020 Dec;20(6):336. doi: 10.3892/ol.2020.12200. Epub 2020 Oct 7.
Oncol Lett. 2020.
PMID: 33123247
Free PMC article.